Full name
A Phase 3b, Open-label, Single-arm Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)
NCT Number
NCT06597344
Geography
US
Locations
United States
Primary Endpoints
Percentage of participants achieving clinical symptom improvement at 24 hours (±4 hours)
External Link
https://clinicaltrials.gov/study/NCT06597344
Order
2
Disease
Version
Phase
3b